• Scientific rationale

    The webinar will face current methodologies to evaluate the sustainability of Hadrontherapy going through the clinical experiences and the ethical aspects. Given that Hadrontherapy is up-to-date addressed to rare tumors, a multidisciplinary collaboration is of utmost importance for its application both for the patients benefit and for Healthcare Systems. The translational research will give the chance to expand the scientific knowledge on the clinical benefits of Hadrontherapy.Moreover National and International Networks and Cooperations are the keys to build clinical evidence for and to maximize the investment for this innovative technology.

  • Programme

    15.00

     Meeting Introduction

    		Ester Orlandi
    15.10

    Alternative strategies for obtaining clinical evidence for hadron therapy.

    		Christian Hammer
    15.30

    Health economic evaluation in planning hadrontherapy

    		Elio Borgonovi
    15.40

    Decision-analytical modelling for economic evaluations in healthcare, with examples in oncology

    		Silvana Quaglini
    15.50

    Ethics and new technologies

    		Virginia Sanchini
    16.10

    The importance of the oncological network

    		Stefano Maria Magrini
    16.30

    Health technology assessment

    		Alexandra Jensen
    16.50

    Traslational research in hadrontherapy: current status and future directions

    		Marco Durante
    17.10

    The role of particle therapy networking: EPTN

    		Cai Grau
    17.30

    Development of a cost-effectiveness model in a randomized trial for hadrontherapy

    		Steven J. Frank
    17.50

    Discussion

    18.00

    Take home messages

    18.05

    Adjourn

  • Registration

    This course is reserved to a limited number of participants.

    Participation in this course is free of charge.

    Completing the online registration is mandatory to attend this course.

  • CME Instructions

    The credit certification for the webinar is subject to:

    - Professions/specializations should correspond to those which have been accredited for CME
    - attendance at the live webinar on the platform fad.accmed.org;
    - the completion of the Meeting evaluation online form;
    - completion of the final test (at least 75% of correct answers). 5 attempts admitted. The test and the meeting evaluation form must be completed within 3 days from the end of the event.

  • Training objective

    Contenuti tecnico-professionali (conoscenze e competenze) specifici di ciascuna professione, di ciascuna specializzazione e di ciascuna attività ultraspecialistica, ivi incluse le malattie rare e la medicina di genere

  • Report Qualità